{"gene":"ARL2","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2002,"finding":"Crystal structure of full-length Arl2-GTP in complex with its effector PDE delta solved at 1.8–2.3 Å resolution. Arl2 undergoes a dramatic conformational change from the GDP-bound form, suggesting reversible membrane association. PDE delta is structurally related to RhoGDI and contains a deep hydrophobic pocket that binds prenylated proteins including H-Ras, Rheb, Rho6, and Gαi1. Arl2-GTP was proposed to act as a regulator of PDE delta-mediated transport of prenylated proteins.","method":"X-ray crystallography (two crystal forms, PDB: 1KSG, 1KSH, 1KSJ); co-expression and copurification; binding assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure solved at high resolution with multiple crystal forms, co-expression/copurification, and binding experiments in a single rigorous study","pmids":["11980706"],"is_preprint":false},{"year":2000,"finding":"Arl2 in its GDP-bound form interacts with tubulin-specific chaperone cofactor D (TBCD) and downregulates the tubulin GAP activity of cofactors C, D, and E, inhibiting binding of D to native tubulin in vitro. GDP-Arl2 specifically prevents tubulin and microtubule destruction caused by cofactor D overexpression in cultured cells, but not by cofactor E. Established using Ras-family-based Arl2 point mutants in vitro and in vivo.","method":"In vitro tubulin GTPase assays; in vitro binding inhibition assays; overexpression in cultured cells; site-directed mutagenesis of Arl2","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (in vitro reconstitution, mutagenesis, cell-based assays) in a single rigorous study; independently supported by later work","pmids":["10831612"],"is_preprint":false},{"year":1999,"finding":"BART (Binder of Arl Two), a 19 kDa novel protein, was purified from bovine brain and identified as the first ARL2-specific effector. BART binds specifically to ARL2·GTP with high affinity but does not interact with ARL2·GDP, activated ARF, or RHO proteins. BART lacks GTPase-activating protein activity toward ARL2.","method":"Affinity purification from bovine brain; recombinant protein binding assays; GTPase activity assays; Northern and Western blot","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — purification of endogenous complex, recombinant protein validation, replicated in multiple subsequent studies","pmids":["10488091"],"is_preprint":false},{"year":2002,"finding":"ARL2 and BART both localize to mitochondria in a protease-resistant form. ARL2 lacks N-myristoylation (unlike other ARF family members), preserving its N-terminal amphipathic helix as a potential mitochondrial import sequence. The BART·ARL2·GTP complex specifically binds the adenine nucleotide transporter ANT1 (but not the homologous ANT2) in mitochondria. Mitochondria from ant1−/− mice showed increased ARL2 levels, indicating that ARL2 in mitochondria is regulated via an ANT1-sensitive pathway.","method":"Subcellular fractionation; protease protection assay; overlay assay; protein purification and microsequencing; ant1−/− knockout mouse mitochondria analysis","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods including protease protection, overlay assay, purification, and genetic knockout validation","pmids":["11809823"],"is_preprint":false},{"year":2007,"finding":"ELMOD2 was purified from bovine testis and identified as an ARL2 GTPase-activating protein (GAP). A second ELMO domain protein, ELMOD1, also has ARL2 GAP activity. Surprisingly, ELMOD2 also exhibits GAP activity against Arf proteins despite lacking the canonical Arf GAP sequence signature.","method":"Protein purification from bovine testis; in vitro GAP activity assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — biochemical purification of endogenous GAP activity and in vitro reconstitution; single lab but rigorous biochemical approach","pmids":["17452337"],"is_preprint":false},{"year":2003,"finding":"Cytosolic Arl2 exists predominantly (~90%) as part of a ~300 kDa complex containing cofactor D (TBCD) and at least two distinct protein phosphatase 2A (PP2A) trimers (all three PP2A subunits identified by mass spectrometry). Arl2 in this complex cannot bind GTP, and complexed cofactor D does not efficiently participate in tubulin refolding reactions. This suggests the complex sequesters both Arl2 and TBCD in inactive states.","method":"Gel filtration; ~500-fold purification from bovine brain soluble fraction; mass spectrometry protein identification; GTP-binding assays; tubulin refolding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — biochemical purification, mass spectrometry identification, and functional activity assays in a single study","pmids":["12912990"],"is_preprint":false},{"year":2002,"finding":"C. elegans evl-20, a functional homolog of human ARL2, is required for cytoskeletal dynamics during cytokinesis and morphogenesis. Loss of evl-20 causes microtubule cytoskeleton defects and developmental abnormalities. EVL-20 localizes to the cell cortex and astral microtubules.","method":"Loss-of-function genetics (C. elegans); immunofluorescence localization; phenotypic analysis","journal":"Developmental cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined cellular phenotype and localization; ortholog of ARL2 in C. elegans","pmids":["12015966"],"is_preprint":false},{"year":2006,"finding":"Expression of constitutively active [Q70L]Arl2 in HeLa cells caused loss of microtubules and cell cycle arrest in M phase, attributed to a defect in tubulin polymerization. Arl2 was found to localize to centrosomes. Arl3 knockdown (not Arl2 knockdown) caused cytokinesis failure and binucleation, distinguishing the two paralogs' roles in microtubule-dependent processes.","method":"siRNA knockdown; dominant-active mutant expression; immunofluorescence; cell cycle analysis","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — multiple mutant/knockdown experiments with defined phenotypic readouts; single lab","pmids":["16525022"],"is_preprint":false},{"year":2009,"finding":"miR-15b targets the 3'-UTR of Arl2 mRNA and suppresses Arl2 mRNA and protein expression. Knockdown of Arl2 by siRNA decreases cellular ATP levels and causes mitochondrial degeneration, phenocopying miR-15b overexpression. Restoration of Arl2 expression rescues the miR-15b-induced reduction in ATP levels.","method":"Luciferase reporter assay (3'-UTR); siRNA knockdown; miRNA overexpression; ATP assay; electron microscopy of mitochondria","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase reporter validation, rescue experiment, and EM phenotype; single lab","pmids":["20007690"],"is_preprint":false},{"year":2013,"finding":"Crystal structure of the RPGR propeller domain in complex with PDEδ was solved, revealing that RPGR binds cargo-loaded PDEδ via a conserved surface patch while exposing the Arl2/Arl3-binding site on PDEδ. Biochemical experiments showed RPGR can bind with high affinity to cargo-loaded PDEδ, suggesting RPGR acts as a scaffold recruiting cargo-loaded PDEδ and Arl3 to release lipidated cargo into cilia.","method":"X-ray crystallography; biochemical binding assays","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure plus biochemical experiments; single lab but multiple orthogonal methods","pmids":["23559067"],"is_preprint":false},{"year":2003,"finding":"HRG4 (UNC119) interacts with ARL2 as identified by yeast two-hybrid; confirmed by co-immunoprecipitation and direct binding assay. ARL2 co-localizes with HRG4 in the retina. Conserved amino acid residues in HRG4 homologous to those in PDEδ that mediate ARL2 binding and form the hydrophobic pocket suggest a similar binding mechanism.","method":"Yeast two-hybrid; co-immunoprecipitation; direct binding assay; Western blot; immunofluorescence","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — multiple complementary binding assays (Y2H, co-IP, direct binding) in a single study","pmids":["12527357"],"is_preprint":false},{"year":2014,"finding":"ARL2 depletion by siRNA impairs mitochondrial morphology (fragmentation), motility, and ATP levels in cultured cells. These mitochondrial roles are distinct from ARL2's roles in tubulin folding. Knockdown of the ARL2 GAP ELMOD2 phenocopies two of three mitochondrial phenotypes of ARL2 siRNA (morphology and motility but not ATP), placing ELMOD2 as a likely effector downstream of ARL2 for mitochondrial functions.","method":"siRNA knockdown; dominant-negative mutant expression; live-cell imaging of mitochondrial morphology and motility; ATP assays; genetic epistasis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple phenotypic readouts and epistasis with ELMOD2; single lab","pmids":["24911211"],"is_preprint":false},{"year":2017,"finding":"ARL2 is present in and required for mitochondrial fusion from the intermembrane space (IMS). Increased ARL2 activity promotes mitochondrial elongation/fusion, while loss of ARL2 decreases fusion rate. Activated ARL2 can partially rescue loss of MFN1 or MFN2 individually but not both together, placing ARL2 upstream of/parallel to mitofusins. IMS-restricted ARL2 constructs were active, while matrix or excluded constructs were inactive. By SIM microscopy, ARL2 and mitofusin immunoreactivities co-localize as puncta along mitochondria.","method":"Dominant-active/dominant-negative mutant expression; mitochondrial fusion assay; targeted subcellular localization constructs; structured illumination microscopy (SIM); MFN1/MFN2 knockout cell epistasis","journal":"Cellular logistics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal approaches (functional assays, localization constructs, KO epistasis, SIM imaging); single lab","pmids":["28944094"],"is_preprint":false},{"year":2019,"finding":"ELMOD2 is required for ARL2-dependent mitochondrial elongation and fusion. Loss of ELMOD2 causes mitochondrial fragmentation and decreased fusion rate; ELMOD2 overexpression promotes tubulation and fusion in a mitofusin-dependent manner. A GAP-dead ELMOD2 mutant retains the ability to promote fusion, indicating ELMOD2 acts as an effector (not purely via GAP activity) downstream of ARL2 and upstream of mitofusins. ELMOD2, ARL2, MFN1/2, Miro1/2, and mitoPLD co-localize at discrete puncta along mitochondria.","method":"siRNA knockdown; ELMOD2 overexpression; GAP-dead mutant expression; mitochondrial fusion assay; confocal microscopy co-localization","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional assays and mutant analysis; single lab, builds on prior ARL2 mitochondrial work","pmids":["30865555"],"is_preprint":false},{"year":2017,"finding":"A trimeric complex of TBCD·ARL2·β-tubulin was purified from mammalian cells and tissues. ARL2 (not β-tubulin) is the GTP-exchanging subunit in the trimer. ARL2 binds GTP with higher affinity in the trimer than as a monomer. ARL2 point mutants that disrupt TBCD binding impair microtubule density in cells. The trimer represents a functional intermediate in the β-tubulin folding pathway regulated by ARL2 nucleotide cycling.","method":"Native PAGE and immunoblotting; purification of trimer from HEK293 cells; hydrogen/deuterium exchange-mass spectrometry; nucleotide-binding assays; ARL2 point mutants; cell-based microtubule density assay","journal":"The Journal of biological chemistry; Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical purification, HDX-MS structural dynamics, nucleotide binding assays, and mutagenesis across two complementary studies from the same lab","pmids":["28126905","28970104"],"is_preprint":false},{"year":2010,"finding":"siRNA-mediated suppression of ARL2 in HeLa cells overcomes the inability of human TBCD (which normally does not disrupt microtubules upon overexpression) to destroy microtubule integrity in vivo, confirming that Arl2 negatively regulates TBCD's microtubule-destructive activity in cells.","method":"siRNA knockdown of Arl2; TBCD overexpression; immunofluorescence of microtubules","journal":"Cytoskeleton","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean siRNA rescue epistasis experiment; single lab, single method","pmids":["20740604"],"is_preprint":false},{"year":2016,"finding":"Drosophila Arl2 controls microtubule growth and asymmetric division of neural stem cells (neuroblasts) by localizing Msps (XMAP215 ortholog) to centrosomes via regulation of dynein function and centrosomal D-TACC/Msps localization. Arl2 physically associates with tubulin cofactors C, D, and E, and functions together with cofactor D (TBCD) to control microtubule growth. Arl2 loss-of-function causes microtubule abnormalities and asymmetric division defects; Arl2 overactivation causes microtubule overgrowth and NB depletion.","method":"RNAi knockdown; dominant-negative and activated mutant expression; co-immunoprecipitation with TBCC/D/E; immunofluorescence; genetic epistasis in Drosophila NBs","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP with multiple cofactors, multiple loss/gain-of-function genetics, imaging in vivo, epistasis; multiple orthogonal methods in Drosophila ortholog","pmids":["26953351"],"is_preprint":false},{"year":2016,"finding":"Arl2 and Arl3 both release prenylated and myristoylated cargo from carrier proteins (PDEδ for prenylated cargo; Unc119a/b for myristoylated cargo), but differ in selectivity: Arl3·GTP exclusively releases high-affinity ciliary cargo from Unc119, while both Arl2·GppNHp and Arl3·GppNHp can release low-affinity cargo. Crystal structure of myristoylated NPHP3 peptide in complex with Unc119a revealed molecular determinants of high-affinity binding; swapping residues at +2/+3 positions reversed cargo affinities and caused partial mislocalization.","method":"X-ray crystallography; fluorescence polarization binding assays; mutagenesis; cell localization studies","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure, quantitative binding assays, mutagenesis, and cell localization in a single study","pmids":["27481943"],"is_preprint":false},{"year":2011,"finding":"BART interacts with GTP-bound ARL2 at the leading edges of migrating pancreatic cancer cells. GTP-bound ARL2 inactivates RhoA, and BART prevents ARL2 from regulating RhoA activity by binding GTP-ARL2, thereby increasing active RhoA levels. BART functions as an inhibitor of ARL2 at leading edges, and BART knockdown reduces active RhoA, increases actin-cytoskeleton rearrangements, and promotes cell invasion.","method":"Co-immunoprecipitation; RhoA activation assay; siRNA knockdown of BART; Rho inhibitor (C3 exoenzyme) treatment; invasion assay; immunofluorescence","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — co-IP, activation assays, and functional knockdown with pharmacological validation; single lab","pmids":["21833473"],"is_preprint":false},{"year":2007,"finding":"In polarized epithelial MDCK cells, ARL2 and TBCD (beta-tubulin cofactor D) participate in apical junctional complex (AJC) disassembly and cell dissociation from the epithelial monolayer independently of microtubule depolymerization. TBCD partially localizes to the lateral plasma membrane via its 15 C-terminal amino acids and requires intact microtubules for this. ARL2 inhibits TBCD-dependent cell dissociation and AJC disassembly.","method":"Overexpression in MDCK cells; immunofluorescence; dominant-active/inactive ARL2 constructs; microtubule depolymerization assays","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — functional overexpression assays with defined phenotypic readout and inhibition by ARL2; single lab","pmids":["17704193"],"is_preprint":false},{"year":2013,"finding":"ELMOD3, a second ELMO domain-containing protein, exhibits GAP activity against Arl2 GTPase; this activity is completely abolished by the disease-causing p.Leu265Ser mutation in the ELMO domain. ELMOD3 co-localizes with the actin cytoskeleton in epithelial cells and is expressed in cochlear hair cell stereocilia.","method":"Recombinant GST-ELMOD3 in vitro GAP assay; site-directed mutagenesis; immunofluorescence; exome sequencing/co-segregation for human genetics","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro GAP assay with mutagenesis validation; single lab","pmids":["24039609"],"is_preprint":false},{"year":2008,"finding":"The solution structure of BART was solved by NMR, revealing a novel fold of six alpha-helices forming three interlocking 'L' shapes. Mapping of ARL2-binding regions onto the surface showed they localize to dynamic loop regions between central helices.","method":"NMR structure determination; backbone dynamics analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — NMR structure solved but functional validation is limited in this paper; single lab","pmids":["18981177"],"is_preprint":false},{"year":2010,"finding":"In Trypanosoma brucei, TbARL2 RNAi causes inhibition of cleavage furrow formation, cytokinesis defects, multinucleation, and loss of acetylated alpha-tubulin (but not total tubulin) from microtubules. Overexpression of myc-tagged (but not untagged) TbARL2 also causes cytokinesis defects, demonstrating importance of the C-terminus for correct function.","method":"RNAi in bloodstream T. brucei; overexpression; immunofluorescence; Western blot","journal":"Molecular and biochemical parasitology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi with defined cellular phenotypes and overexpression controls; ortholog of ARL2 in protozoan","pmids":["20653091"],"is_preprint":false},{"year":2013,"finding":"Fission yeast cofactor C ortholog Tbc1 acts as a GAP for Alp41/Arl2 (S. pombe Arl2). Continuous cycling between GDP- and GTP-bound Alp41 is required for microtubule function (both constitutive GDP and GTP forms cause microtubule loss). GDP-bound Alp41 interacts with Alp1D (cofactor D ortholog), and Alp1D co-overproduction with GDP-Alp41 prevents Alp1D-induced microtubule depolymerization.","method":"In vitro GAP assay; genetic analysis of GDP/GTP mutants in S. pombe; co-immunoprecipitation; fluorescence microscopy","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro GAP assay, genetic epistasis, Co-IP in fission yeast ortholog; single lab","pmids":["23576550"],"is_preprint":false},{"year":2017,"finding":"Novel PDE6δ inhibitors with picomolar affinity (up to 7 hydrogen bonds to PDE6δ) are poorly released from PDE6δ by Arl2, unlike earlier lower-affinity inhibitors that are rapidly displaced. This demonstrates that Arl2 functions as a release factor for PDE6δ-bound cargo/inhibitors and that inhibitor affinity determines the efficiency of Arl2-mediated displacement.","method":"Biophysical binding assays (SPR/ITC); cellular KRas signaling assays; cell viability assays; structure-activity relationship chemistry","journal":"Angewandte Chemie","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — binding assays plus cellular functional assays; mechanistic point about Arl2 release activity validated with chemical probes","pmids":["28106325"],"is_preprint":false},{"year":2015,"finding":"Arl2 binds to membranes in a nucleotide-independent manner (unlike Arl3 and other Arfs that require GTP for membrane interaction). Arl2 and Arl3 both preferentially localize to liquid-disordered membrane domains. In contrast to Arl3, the N-terminal helix of Arl2 does not increase binding affinity to UNC119a, and UNC119a does not impede Arl2 membrane binding.","method":"Biophysical membrane-binding assays (fluorescence spectroscopy with phase-separated vesicles); nucleotide loading comparisons","journal":"Biophysical journal","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — rigorous biophysical assays but single lab, distinguishing Arl2 from Arl3 membrane behavior","pmids":["26488653"],"is_preprint":false},{"year":2018,"finding":"Molecular dynamics simulations revealed that Arl2·GTP binding to PDE6δ allosterically compresses the hydrophobic pocket via changes in β6 of PDEδ and additional residues, pushing the KRas4B farnesylated HVR out. Mutating PDEδ residues mediating these allosteric changes abolishes the release process.","method":"All-atom molecular dynamics simulation; mutational analysis of PDEδ allosteric residues","journal":"The journal of physical chemistry B","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational study only; mutagenesis is in silico; no experimental validation in this paper","pmids":["29961325"],"is_preprint":false},{"year":2024,"finding":"Mouse Arl2 physically associates with the centrosomal protein Cdk5rap2, validated by co-immunoprecipitation and proximity ligation assay (PLA). Arl2 knockdown in mouse neural progenitor cells reduces centrosomal microtubule growth and delocalizes centrosomal proteins Cdk5rap2 and γ-tubulin. Overexpression of Cdk5rap2 rescues the neurogenesis defects caused by Arl2 knockdown, placing Cdk5rap2 downstream of Arl2 in cortical development.","method":"Co-immunoprecipitation; proximity ligation assay; in utero electroporation knockdown; rescue by Cdk5rap2 overexpression; live imaging of centrosomal microtubule growth","journal":"PLoS biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus PLA for interaction, genetic rescue epistasis, live imaging; single lab","pmids":["39137170"],"is_preprint":false},{"year":2022,"finding":"Conditional deletion of ARL2 in the mouse retina early in development (retArl2−/−) disrupts the microtubule cytoskeleton as early as postnatal day 6, prevents rod and cone outer segment formation, and reduces cytoplasmic dynein levels in inner segments, suggesting dynein stability depends on a functional microtubule cytoskeleton organized by ARL2. Rod-specific late deletion was stable, indicating ARL2 is specifically required during early photoreceptor development for microtubule neogenesis.","method":"Conditional knockout mouse; immunofluorescence; Western blot; ERG functional assay","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with multiple cellular phenotype readouts; single lab","pmids":["36611941"],"is_preprint":false},{"year":2019,"finding":"A de novo variant in ARL2 (p.R15L) causes MRCS syndrome. Co-immunoprecipitation showed the mutant ARL2 protein has 62% lower binding affinity for HRG4 but only 18% lower binding affinity for ARL2BP. ARL2 and HRG4 co-localize with cytochrome c in HeLa cells, indicating mitochondrial co-localization. Mutant ARL2 causes abnormalities in mitochondrial respiratory chain function and ATP production. Transgenic mice expressing the mutant develop retinal degeneration, microcornea, and cataract.","method":"Co-immunoprecipitation; immunofluorescence; mitochondrial function assays; ATP production assay; site-directed mutagenesis; transgenic mouse model","journal":"Clinical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (Co-IP, functional assays, transgenic model); single lab","pmids":["30945270"],"is_preprint":false},{"year":2022,"finding":"ARL2 is required for homologous recombination repair (HRR) in colon cancer stem cells (CSCs). ARL2 depletion leads to DNA double-strand break accumulation and apoptosis specifically in CSCs. ARL2 is detected within chromatin compartments and its expression correlates with RAD51 family gene expression.","method":"siRNA depletion; DNA damage assays; subcellular fractionation (chromatin compartment); flow cytometry (apoptosis, cell cycle)","journal":"FEBS open bio","confidence":"Low","confidence_rationale":"Tier 3 / Weak — functional knockdown with chromatin fractionation; single lab, limited mechanistic detail on how ARL2 mediates HRR","pmids":["35567502"],"is_preprint":false}],"current_model":"ARL2 is a small regulatory GTPase that cycles between GDP- and GTP-bound states (regulated by GAPs including ELMOD1/2/3 and TBCC/Tbc1) and functions in at least three distinct cellular contexts: (1) in the cytosol, GDP-ARL2 binds tubulin chaperone TBCD within a TBCD·ARL2·β-tubulin trimer to regulate β-tubulin folding and microtubule dynamics, inhibiting TBCD's destructive activity while ARL2 nucleotide exchange drives conformational changes in β-tubulin; (2) inside mitochondria (in the intermembrane space, lacking N-myristoylation), ARL2·GTP promotes mitochondrial fusion via the ELMOD2 effector acting upstream of mitofusins, and interacts with ANT1 to regulate adenine nucleotide transport and ATP levels; and (3) in the context of lipidated cargo trafficking, ARL2·GTP and Arl3·GTP act as release factors from carrier proteins PDE6δ (for farnesylated cargo such as KRas) and UNC119 (for myristoylated cargo), with Arl3 exclusively releasing high-affinity ciliary cargo while Arl2 releases low-affinity cargo, supporting a spatial sorting mechanism for protein delivery to cilia and the plasma membrane."},"narrative":{"mechanistic_narrative":"ARL2 is a small ADP-ribosylation factor-like GTPase that cycles between GDP- and GTP-bound states and coordinates microtubule biogenesis, mitochondrial function, and the trafficking of lipidated proteins across spatially distinct cellular pools [PMID:11980706, PMID:10831612, PMID:24911211]. Its nucleotide cycle is governed by GAPs of the ELMO-domain family (ELMOD1, ELMOD2, ELMOD3) and by tubulin cofactor C orthologs, with continuous GDP/GTP cycling required for activity [PMID:17452337, PMID:24039609, PMID:23576550]. In the cytosol, GDP-bound ARL2 binds tubulin-specific chaperone cofactor D (TBCD) and assembles into a TBCD·ARL2·β-tubulin trimer in which ARL2 is the GTP-exchanging subunit; through this complex ARL2 restrains TBCD's tubulin- and microtubule-destructive activity and drives the β-tubulin folding pathway, controlling microtubule density, centrosomal microtubule growth, and cell-cycle progression [PMID:10831612, PMID:12912990, PMID:28126905, PMID:28970104, PMID:20740604, PMID:39137170]. Inside mitochondria, where ARL2 escapes N-myristoylation and is imported to the intermembrane space, ARL2·GTP promotes mitochondrial fusion through the ELMOD2 effector acting with the mitofusins and regulates ATP levels and mitochondrial morphology, in part via interaction with the adenine nucleotide transporter ANT1 [PMID:11809823, PMID:24911211, PMID:28944094, PMID:30865555]. In lipidated-cargo trafficking, ARL2·GTP acts as a release factor that allosterically expels prenylated cargo from the carrier PDEδ and myristoylated cargo from UNC119, with ARL2 releasing low-affinity cargo while the paralog Arl3 handles high-affinity ciliary cargo, establishing a spatial sorting mechanism [PMID:11980706, PMID:27481943, PMID:28106325]. The dedicated effector BART (BinderofArlTwo) binds ARL2·GTP specifically and modulates its activity, including at the leading edge of migrating cells where it antagonizes ARL2-dependent suppression of RhoA [PMID:10488091, PMID:21833473]. A de novo ARL2 variant (p.R15L) that weakens binding to HRG4/UNC119 causes MRCS syndrome with retinal degeneration, microcornea, and cataract [PMID:30945270].","teleology":[{"year":1999,"claim":"Establishing that ARL2 has dedicated GTP-state-specific effectors answered whether it functions as a genuine signaling GTPase rather than a structural ARF; BART was the first such effector identified.","evidence":"Affinity purification of BART from bovine brain with recombinant binding and GTPase assays","pmids":["10488091"],"confidence":"High","gaps":["Cellular consequence of BART binding undefined at discovery","No structure of the ARL2-BART complex"]},{"year":2000,"claim":"Linking GDP-ARL2 to the tubulin chaperone cofactor D established its first concrete role: a negative regulator of cofactor-driven tubulin destruction and microtubule integrity.","evidence":"In vitro tubulin GTPase and binding-inhibition assays plus cofactor overexpression in cultured cells with ARL2 point mutants","pmids":["10831612"],"confidence":"High","gaps":["Did not resolve whether ARL2 is part of a stable trimer with tubulin","Nucleotide-cycle requirement not directly tested"]},{"year":2002,"claim":"Solving the Arl2-GTP·PDEδ structure showed how ARL2 nucleotide state controls a prenyl-binding carrier, framing ARL2 as a regulator of prenylated-protein transport.","evidence":"X-ray crystallography of full-length Arl2-GTP·PDEδ in two crystal forms with binding assays","pmids":["11980706"],"confidence":"High","gaps":["Release mechanism for cargo not directly demonstrated","In vivo trafficking consequences not tested"]},{"year":2002,"claim":"Demonstrating mitochondrial localization and ANT1 binding of the BART·ARL2·GTP complex revealed an unexpected second compartment for ARL2 beyond tubulin folding.","evidence":"Subcellular fractionation, protease protection, overlay assay, and ant1-/- mouse mitochondria analysis","pmids":["11809823"],"confidence":"High","gaps":["Functional role of ANT1 interaction not established","Mechanism of mitochondrial import not defined"]},{"year":2003,"claim":"Defining the ~300 kDa cytosolic ARL2-TBCD-PP2A complex clarified that most cellular ARL2 is held in a GTP-incompetent, sequestered state, implying regulated release governs activity.","evidence":"Gel filtration, purification from bovine brain, mass spectrometry, GTP-binding and tubulin refolding assays","pmids":["12912990"],"confidence":"High","gaps":["Signal that releases ARL2/TBCD from the complex unknown","Role of PP2A in the complex not mechanistically resolved"]},{"year":2003,"claim":"Identifying UNC119/HRG4 as an ARL2 partner extended the carrier-protein paradigm from prenylated to myristoylated cargo and connected ARL2 to retinal biology.","evidence":"Yeast two-hybrid, co-IP, direct binding, and retinal co-localization","pmids":["12527357"],"confidence":"Medium","gaps":["Cargo release from UNC119 not yet shown","Functional retinal consequence not tested"]},{"year":2006,"claim":"Showing that constitutively active ARL2 destroys microtubules and arrests cells in M phase while distinguishing ARL2 from Arl3 separated the paralogs' roles in microtubule-dependent processes.","evidence":"siRNA knockdown, dominant-active mutant expression, immunofluorescence, and cell-cycle analysis in HeLa cells","pmids":["16525022"],"confidence":"Medium","gaps":["Centrosomal function of ARL2 not mechanistically defined","Single-lab phenotype"]},{"year":2007,"claim":"Identifying ELMOD2 (and ELMOD1) as ARL2 GAPs provided the missing regulators that terminate ARL2 signaling, defining the off-switch of its cycle.","evidence":"Purification of GAP activity from bovine testis and in vitro GAP assays","pmids":["17452337"],"confidence":"High","gaps":["Which ARL2 functions each GAP regulates not yet assigned","Cross-activity toward Arf raised specificity questions"]},{"year":2013,"claim":"Identifying ELMOD3 as a third ARL2 GAP whose activity is abolished by a disease mutation, and resolving RPGR scaffolding of cargo-loaded PDEδ, sharpened both the regulatory network and the ciliary-delivery model.","evidence":"In vitro GAP assays with mutagenesis (ELMOD3) and crystallography with binding assays (RPGR-PDEδ)","pmids":["24039609","23559067"],"confidence":"Medium","gaps":["Direct role of ARL2 (vs Arl3) in RPGR-mediated release not pinned down","Tissue specificity of GAP usage unclear"]},{"year":2014,"claim":"Separating ARL2's mitochondrial phenotypes (morphology, motility, ATP) from its tubulin role, and placing ELMOD2 downstream, established a distinct mitochondrial pathway.","evidence":"siRNA knockdown, dominant-negative expression, live imaging, ATP assays, and ELMOD2 epistasis","pmids":["24911211"],"confidence":"Medium","gaps":["Molecular target of ARL2 in mitochondria not identified","ATP defect not phenocopied by ELMOD2 loss"]},{"year":2016,"claim":"Demonstrating ARL2/Arl3 cargo release and its affinity-based selectivity, and dissecting ARL2's centrosomal microtubule control in Drosophila neuroblasts, unified the trafficking and microtubule arms mechanistically.","evidence":"Crystallography and fluorescence polarization (cargo release); RNAi, Co-IP with cofactors C/D/E, and imaging in Drosophila neuroblasts","pmids":["27481943","26953351"],"confidence":"High","gaps":["How a single GTPase is partitioned among compartments unresolved","Quantitative cargo handoff to membranes in cells incomplete"]},{"year":2017,"claim":"Reconstituting the TBCD·ARL2·β-tubulin trimer with ARL2 as the GTP-exchanging subunit, and showing IMS-restricted ARL2 drives mitofusin-dependent fusion, gave direct biochemical mechanism for both the tubulin-folding and mitochondrial-fusion roles.","evidence":"Trimer purification with HDX-MS and nucleotide assays; targeted localization constructs, fusion assays, SIM, and MFN1/2 KO epistasis","pmids":["28126905","28970104","28944094"],"confidence":"High","gaps":["Structural basis of ARL2-induced β-tubulin conformational change not at atomic resolution","Effector linking ARL2 to mitofusins not yet identified in this study"]},{"year":2019,"claim":"Showing ELMOD2 acts as a GAP-independent effector for ARL2-driven mitochondrial fusion, alongside identifying an ARL2 disease variant, connected mechanism to human pathology.","evidence":"GAP-dead ELMOD2 mutant fusion assays and co-localization; Co-IP, mitochondrial function assays, and transgenic mouse for the p.R15L MRCS variant","pmids":["30865555","30945270"],"confidence":"Medium","gaps":["How the same ELMOD2 serves both GAP and effector roles unclear","Whether MRCS pathology is primarily trafficking- or mitochondria-driven not resolved"]},{"year":2024,"claim":"Identifying Cdk5rap2 as an ARL2-associated centrosomal target whose overexpression rescues ARL2-loss neurogenesis defects extended ARL2's microtubule role into cortical development.","evidence":"Co-IP, proximity ligation, in utero electroporation knockdown, rescue, and live imaging in mouse neural progenitors","pmids":["39137170"],"confidence":"Medium","gaps":["Whether ARL2 nucleotide state controls Cdk5rap2 localization unknown","Direct vs indirect interaction not fully resolved"]},{"year":null,"claim":"How a single GTPase is partitioned and selectively activated across its cytosolic tubulin-folding, mitochondrial, and membrane-trafficking pools, and how its sequestered cytosolic complex is mobilized, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No mechanism for compartment-specific GEF/GAP targeting","Release mechanism from the inhibitory TBCD-PP2A complex unknown","ARL2 chromatin/HRR role (Low confidence) lacks direct mechanism"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[4,14,20,23]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,15,17,24]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[1,14,16]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5,14]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[3,11,12,13]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[7,27]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[25,18]}],"pathway":[{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[1,14,12]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[0,17]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[7]}],"complexes":["TBCD·ARL2·β-tubulin trimer","ARL2-TBCD-PP2A ~300 kDa complex","BART·ARL2·GTP complex"],"partners":["TBCD","BART","PDE6D","UNC119","ELMOD2","ANT1","CDK5RAP2","ELMOD3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P36404","full_name":"ADP-ribosylation factor-like protein 2","aliases":[],"length_aa":184,"mass_kda":20.9,"function":"Small GTP-binding protein which cycles between an inactive GDP-bound and an active GTP-bound form, and the rate of cycling is regulated by guanine nucleotide exchange factors (GEF) and GTPase-activating proteins (GAP). GTP-binding protein that does not act as an allosteric activator of the cholera toxin catalytic subunit. Regulates formation of new microtubules and centrosome integrity. Prevents the TBCD-induced microtubule destruction. Participates in association with TBCD, in the disassembly of the apical junction complexes. Antagonizes the effect of TBCD on epithelial cell detachment and tight and adherens junctions disassembly. Together with ARL2, plays a role in the nuclear translocation, retention and transcriptional activity of STAT3. Component of a regulated secretory pathway involved in Ca(2+)-dependent release of acetylcholine. Required for normal progress through the cell cycle (PubMed:10831612, PubMed:16525022, PubMed:18234692, PubMed:18588884, PubMed:20740604). Also regulates mitochondrial integrity and function (PubMed:30945270)","subcellular_location":"Mitochondrion intermembrane space; Cytoplasm, cytoskeleton, microtubule organizing center, centrosome; Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P36404/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/ARL2","classification":"Common Essential","n_dependent_lines":1199,"n_total_lines":1208,"dependency_fraction":0.9925496688741722},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000213465","cell_line_id":"CID000490","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleoplasm","grade":3},{"compartment":"big_aggregates","grade":2}],"interactors":[{"gene":"TBCD","stoichiometry":10.0},{"gene":"ARL2-SNX15;ARL2","stoichiometry":10.0},{"gene":"TUBB4B","stoichiometry":10.0},{"gene":"YWHAB","stoichiometry":4.0},{"gene":"YWHAH","stoichiometry":4.0},{"gene":"TUBB4A","stoichiometry":0.2},{"gene":"YWHAE","stoichiometry":0.2},{"gene":"YWHAZ","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000490","total_profiled":1310},"omim":[{"mim_id":"620513","title":"UNC119 LIPID-BINDING CHAPERONE B; UNC119B","url":"https://www.omim.org/entry/620513"},{"mim_id":"620058","title":"FAMILIAL APOLIPOPROTEIN GENE CLUSTER DELETION SYNDROME","url":"https://www.omim.org/entry/620058"},{"mim_id":"619572","title":"MICRO RNA 15B; MIR15B","url":"https://www.omim.org/entry/619572"},{"mim_id":"619397","title":"ZINC FINGER PROTEIN-LIKE 1; ZFPL1","url":"https://www.omim.org/entry/619397"},{"mim_id":"619082","title":"MICROCORNEA, ROD-CONE DYSTROPHY, CATARACT, AND POSTERIOR STAPHYLOMA 1; MRCS1","url":"https://www.omim.org/entry/619082"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Basal body","reliability":"Approved"},{"location":"Flagellar centriole","reliability":"Approved"},{"location":"Nucleoli","reliability":"Additional"},{"location":"Mitochondria","reliability":"Additional"},{"location":"Equatorial segment","reliability":"Additional"},{"location":"Mid piece","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ARL2"},"hgnc":{"alias_symbol":["ARFL2"],"prev_symbol":[]},"alphafold":{"accession":"P36404","domains":[{"cath_id":"3.40.50.300","chopping":"9-180","consensus_level":"high","plddt":96.1782,"start":9,"end":180}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P36404","model_url":"https://alphafold.ebi.ac.uk/files/AF-P36404-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P36404-F1-predicted_aligned_error_v6.png","plddt_mean":94.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ARL2","jax_strain_url":"https://www.jax.org/strain/search?query=ARL2"},"sequence":{"accession":"P36404","fasta_url":"https://rest.uniprot.org/uniprotkb/P36404.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P36404/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P36404"}},"corpus_meta":[{"pmid":"11980706","id":"PMC_11980706","title":"The complex of Arl2-GTP and PDE delta: from structure to function.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11980706","citation_count":192,"is_preprint":false},{"pmid":"10831612","id":"PMC_10831612","title":"ADP ribosylation factor-like protein 2 (Arl2) regulates the interaction of tubulin-folding cofactor D with native tubulin.","date":"2000","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10831612","citation_count":184,"is_preprint":false},{"pmid":"16525022","id":"PMC_16525022","title":"Arl2 and Arl3 regulate different microtubule-dependent processes.","date":"2006","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/16525022","citation_count":135,"is_preprint":false},{"pmid":"18047472","id":"PMC_18047472","title":"ARL2, ARG1 and PIN3 define a gravity signal transduction pathway in root statocytes.","date":"2007","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18047472","citation_count":132,"is_preprint":false},{"pmid":"20007690","id":"PMC_20007690","title":"MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20007690","citation_count":129,"is_preprint":false},{"pmid":"29130995","id":"PMC_29130995","title":"LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the MiR-195/ARL2 Signaling Pathway.","date":"2017","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29130995","citation_count":99,"is_preprint":false},{"pmid":"11809823","id":"PMC_11809823","title":"ARL2 and BART enter mitochondria and bind the adenine nucleotide transporter.","date":"2002","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/11809823","citation_count":76,"is_preprint":false},{"pmid":"28106325","id":"PMC_28106325","title":"A PDE6δ-KRas Inhibitor Chemotype with up to Seven H-Bonds and Picomolar Affinity that Prevents Efficient Inhibitor Release by Arl2.","date":"2017","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/28106325","citation_count":75,"is_preprint":false},{"pmid":"17452337","id":"PMC_17452337","title":"ELMOD2 is an Arl2 GTPase-activating protein that also acts on Arfs.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17452337","citation_count":74,"is_preprint":false},{"pmid":"23559067","id":"PMC_23559067","title":"The interplay between RPGR, PDEδ and Arl2/3 regulate the ciliary targeting of farnesylated cargo.","date":"2013","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/23559067","citation_count":64,"is_preprint":false},{"pmid":"12015966","id":"PMC_12015966","title":"The C. elegans evl-20 gene is a homolog of the small GTPase ARL2 and regulates cytoskeleton dynamics during cytokinesis and morphogenesis.","date":"2002","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/12015966","citation_count":56,"is_preprint":false},{"pmid":"10488091","id":"PMC_10488091","title":"The ARF-like 2 (ARL2)-binding protein, BART. Purification, cloning, and initial characterization.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10488091","citation_count":54,"is_preprint":false},{"pmid":"12912990","id":"PMC_12912990","title":"Cytosolic Arl2 is complexed with cofactor D and protein phosphatase 2A.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12912990","citation_count":50,"is_preprint":false},{"pmid":"28137590","id":"PMC_28137590","title":"miR-214 down-regulates ARL2 and suppresses growth and invasion of cervical cancer cells.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28137590","citation_count":49,"is_preprint":false},{"pmid":"34389797","id":"PMC_34389797","title":"LncRNA XIST shuttled by adipose tissue-derived mesenchymal stem cell-derived extracellular vesicles suppresses myocardial pyroptosis in atrial fibrillation by disrupting miR-214-3p-mediated Arl2 inhibition.","date":"2021","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/34389797","citation_count":45,"is_preprint":false},{"pmid":"12527357","id":"PMC_12527357","title":"Photoreceptor synaptic protein HRG4 (UNC119) interacts with ARL2 via a putative conserved domain.","date":"2003","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12527357","citation_count":44,"is_preprint":false},{"pmid":"20740604","id":"PMC_20740604","title":"Effect of TBCD and its regulatory interactor Arl2 on tubulin and microtubule integrity.","date":"2010","source":"Cytoskeleton (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/20740604","citation_count":41,"is_preprint":false},{"pmid":"27481943","id":"PMC_27481943","title":"Novel Biochemical and Structural Insights into the Interaction of Myristoylated Cargo with Unc119 Protein and Their Release by Arl2/3.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27481943","citation_count":41,"is_preprint":false},{"pmid":"27806215","id":"PMC_27806215","title":"Sorting of lipidated cargo by the Arl2/Arl3 system.","date":"2016","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/27806215","citation_count":40,"is_preprint":false},{"pmid":"24911211","id":"PMC_24911211","title":"The ARL2 GTPase is required for mitochondrial morphology, motility, and maintenance of ATP levels.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24911211","citation_count":40,"is_preprint":false},{"pmid":"28126905","id":"PMC_28126905","title":"A Trimer Consisting of the Tubulin-specific Chaperone D (TBCD), Regulatory GTPase ARL2, and β-Tubulin Is Required for Maintaining the Microtubule Network.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28126905","citation_count":40,"is_preprint":false},{"pmid":"24039609","id":"PMC_24039609","title":"An alteration in ELMOD3, an Arl2 GTPase-activating protein, is associated with hearing impairment in humans.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24039609","citation_count":39,"is_preprint":false},{"pmid":"33270982","id":"PMC_33270982","title":"miR-15a-5p and miR-21-5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33270982","citation_count":37,"is_preprint":false},{"pmid":"20653091","id":"PMC_20653091","title":"The small GTPase ARL2 is required for cytokinesis in Trypanosoma brucei.","date":"2010","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/20653091","citation_count":33,"is_preprint":false},{"pmid":"17188265","id":"PMC_17188265","title":"ADP ribosylation factor like 2 (Arl2) protein influences microtubule dynamics in breast cancer cells.","date":"2006","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/17188265","citation_count":32,"is_preprint":false},{"pmid":"31670868","id":"PMC_31670868","title":"Long non-coding RNA ANRIL enhances mitochondrial function of hepatocellular carcinoma by regulating the MiR-199a-5p/ARL2 axis.","date":"2019","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/31670868","citation_count":27,"is_preprint":false},{"pmid":"29843637","id":"PMC_29843637","title":"ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL.","date":"2018","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29843637","citation_count":26,"is_preprint":false},{"pmid":"18818514","id":"PMC_18818514","title":"Expression of Arl2 is associated with p53 localization and chemosensitivity in a breast cancer cell line.","date":"2008","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/18818514","citation_count":26,"is_preprint":false},{"pmid":"31858533","id":"PMC_31858533","title":"MiR-195-5p inhibits the cell migration and invasion of cervical carcinoma through suppressing ARL2.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31858533","citation_count":25,"is_preprint":false},{"pmid":"33061617","id":"PMC_33061617","title":"Circ_0084927 Facilitates Cervical Cancer Development via Sponging miR-142-3p and Upregulating ARL2.","date":"2020","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/33061617","citation_count":24,"is_preprint":false},{"pmid":"19829707","id":"PMC_19829707","title":"ADP ribosylation factor like 2 (Arl2) regulates breast tumor aggressivity in immunodeficient mice.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19829707","citation_count":22,"is_preprint":false},{"pmid":"32930970","id":"PMC_32930970","title":"Long non-coding RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes stem cell-like properties of gastric cancer cells by regulating the miR-3619-5p/ARL2 axis.","date":"2020","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/32930970","citation_count":21,"is_preprint":false},{"pmid":"28944094","id":"PMC_28944094","title":"The ARL2 GTPase regulates mitochondrial fusion from the intermembrane space.","date":"2017","source":"Cellular logistics","url":"https://pubmed.ncbi.nlm.nih.gov/28944094","citation_count":21,"is_preprint":false},{"pmid":"17704193","id":"PMC_17704193","title":"Beta-tubulin cofactor D and ARL2 take part in apical junctional complex disassembly and abrogate epithelial structure.","date":"2007","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/17704193","citation_count":21,"is_preprint":false},{"pmid":"26953351","id":"PMC_26953351","title":"Arl2- and Msps-dependent microtubule growth governs asymmetric division.","date":"2016","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/26953351","citation_count":20,"is_preprint":false},{"pmid":"30865555","id":"PMC_30865555","title":"ELMOD2 regulates mitochondrial fusion in a mitofusin-dependent manner, downstream of ARL2.","date":"2019","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/30865555","citation_count":19,"is_preprint":false},{"pmid":"31014992","id":"PMC_31014992","title":"Role of Arf-like proteins (Arl1 and Arl2) of Mucor circinelloides in virulence and antifungal susceptibility.","date":"2019","source":"Fungal genetics and biology : FG & B","url":"https://pubmed.ncbi.nlm.nih.gov/31014992","citation_count":19,"is_preprint":false},{"pmid":"19704815","id":"PMC_19704815","title":"ARG1 and ARL2 form an actin-based gravity-signaling chaperone complex in root statocytes?","date":"2008","source":"Plant signaling & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/19704815","citation_count":19,"is_preprint":false},{"pmid":"27400436","id":"PMC_27400436","title":"Higher order signaling: ARL2 as regulator of both mitochondrial fusion and microtubule dynamics allows integration of 2 essential cell functions.","date":"2016","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/27400436","citation_count":18,"is_preprint":false},{"pmid":"28970104","id":"PMC_28970104","title":"Nucleotide Binding to ARL2 in the TBCD∙ARL2∙β-Tubulin Complex Drives Conformational Changes in β-Tubulin.","date":"2017","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28970104","citation_count":17,"is_preprint":false},{"pmid":"33817293","id":"PMC_33817293","title":"LncRNA PVT1 promotes cervical cancer progression by sponging miR-503 to upregulate ARL2 expression.","date":"2021","source":"Open life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33817293","citation_count":17,"is_preprint":false},{"pmid":"30945270","id":"PMC_30945270","title":"Whole-exome sequencing identified ARL2 as a novel candidate gene for MRCS (microcornea, rod-cone dystrophy, cataract, and posterior staphyloma) syndrome.","date":"2019","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30945270","citation_count":16,"is_preprint":false},{"pmid":"26488653","id":"PMC_26488653","title":"Effect of the N-Terminal Helix and Nucleotide Loading on the Membrane and Effector Binding of Arl2/3.","date":"2015","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/26488653","citation_count":16,"is_preprint":false},{"pmid":"32799553","id":"PMC_32799553","title":"GAS6-AS2 Promotes Hepatocellular Carcinoma via miR-3619-5p/ARL2 Axis Under Insufficient Radiofrequency Ablation Condition.","date":"2020","source":"Cancer biotherapy & radiopharmaceuticals","url":"https://pubmed.ncbi.nlm.nih.gov/32799553","citation_count":16,"is_preprint":false},{"pmid":"16413291","id":"PMC_16413291","title":"Assays used in the analysis of Arl2 and its binding partners.","date":"2005","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/16413291","citation_count":13,"is_preprint":false},{"pmid":"21833473","id":"PMC_21833473","title":"BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation.","date":"2011","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/21833473","citation_count":13,"is_preprint":false},{"pmid":"30446707","id":"PMC_30446707","title":"ADP-Ribosylation Factor-Like 2 (ARL2) regulates cilia stability and development of outer segments in rod photoreceptor neurons.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30446707","citation_count":13,"is_preprint":false},{"pmid":"11468408","id":"PMC_11468408","title":"Coexpression, copurification, crystallization and preliminary X-ray analysis of a complex of ARL2-GTP and PDE delta.","date":"2001","source":"Acta crystallographica. Section D, Biological crystallography","url":"https://pubmed.ncbi.nlm.nih.gov/11468408","citation_count":13,"is_preprint":false},{"pmid":"26427472","id":"PMC_26427472","title":"The Function of Arf-like Proteins ARL2 and ARL3 in Photoreceptors.","date":"2016","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/26427472","citation_count":12,"is_preprint":false},{"pmid":"23576550","id":"PMC_23576550","title":"The dual role of fission yeast Tbc1/cofactor C orchestrates microtubule homeostasis in tubulin folding and acts as a GAP for GTPase Alp41/Arl2.","date":"2013","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/23576550","citation_count":11,"is_preprint":false},{"pmid":"33617480","id":"PMC_33617480","title":"Circ_0000527 promotes osteosarcoma cell progression through modulating miR-646/ARL2 axis.","date":"2021","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/33617480","citation_count":10,"is_preprint":false},{"pmid":"29961325","id":"PMC_29961325","title":"Arl2-Mediated Allosteric Release of Farnesylated KRas4B from Shuttling Factor PDEδ.","date":"2018","source":"The journal of physical chemistry. B","url":"https://pubmed.ncbi.nlm.nih.gov/29961325","citation_count":10,"is_preprint":false},{"pmid":"18981177","id":"PMC_18981177","title":"The structure of binder of Arl2 (BART) reveals a novel G protein binding domain: implications for function.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18981177","citation_count":10,"is_preprint":false},{"pmid":"32540185","id":"PMC_32540185","title":"Arf-like proteins (Arl1 and Arl2) are involved in mitochondrial homeostasis in Mucor circinelloides.","date":"2020","source":"Fungal biology","url":"https://pubmed.ncbi.nlm.nih.gov/32540185","citation_count":9,"is_preprint":false},{"pmid":"36300495","id":"PMC_36300495","title":"Circ_0085616 contributes to the radio-resistance and progression of cervical cancer by targeting miR-541-3p/ARL2 signaling.","date":"2022","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/36300495","citation_count":6,"is_preprint":false},{"pmid":"36429022","id":"PMC_36429022","title":"Herpes Simplex Type 1 UL43 Multiple Membrane-Spanning Protein Increases Energy Metabolism in Host Cells through Interacting with ARL2.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36429022","citation_count":5,"is_preprint":false},{"pmid":"36611941","id":"PMC_36611941","title":"Arf-like Protein 2 (ARL2) Controls Microtubule Neogenesis during Early Postnatal Photoreceptor Development.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36611941","citation_count":2,"is_preprint":false},{"pmid":"39137170","id":"PMC_39137170","title":"Arl2 GTPase associates with the centrosomal protein Cdk5rap2 to regulate cortical development via microtubule organization.","date":"2024","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/39137170","citation_count":2,"is_preprint":false},{"pmid":"33574935","id":"PMC_33574935","title":"Regulation of ARL2 in colorectal cancer cell proliferation and tumorigenicity, and its negative association with AXL.","date":"2021","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/33574935","citation_count":2,"is_preprint":false},{"pmid":"35567502","id":"PMC_35567502","title":"ARL2 is required for homologous recombination repair and colon cancer stem cell survival.","date":"2022","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/35567502","citation_count":2,"is_preprint":false},{"pmid":"19636941","id":"PMC_19636941","title":"1H, 13C and 15N resonance assignments for Binder of Arl2, BART.","date":"2008","source":"Biomolecular NMR assignments","url":"https://pubmed.ncbi.nlm.nih.gov/19636941","citation_count":2,"is_preprint":false},{"pmid":"37483470","id":"PMC_37483470","title":"Long Non-Coding RNA ZSCAN16-AS1 Promotes the Malignant Progression of Melanoma Through Regulating the miR-503-5p/ARL2 Axis.","date":"2023","source":"Clinical, cosmetic and investigational dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/37483470","citation_count":1,"is_preprint":false},{"pmid":"37916316","id":"PMC_37916316","title":"Retraction Note: MiR-195-5p inhibits the cell migration and invasion of cervical carcinoma through suppressing ARL2.","date":"2023","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37916316","citation_count":1,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.03.01.641011","title":"Identification of Genes Required for Spatial Control and Mechanical Resilience of Cytokinesis during  <i>Caenorhabditis elegans</i>  Embryogenesis","date":"2025-03-03","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.01.641011","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":31738,"output_tokens":8431,"usd":0.110839,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18210,"output_tokens":4925,"usd":0.107088,"stage2_stop_reason":"end_turn"},"total_usd":0.217927,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"Crystal structure of full-length Arl2-GTP in complex with its effector PDE delta solved at 1.8–2.3 Å resolution. Arl2 undergoes a dramatic conformational change from the GDP-bound form, suggesting reversible membrane association. PDE delta is structurally related to RhoGDI and contains a deep hydrophobic pocket that binds prenylated proteins including H-Ras, Rheb, Rho6, and Gαi1. Arl2-GTP was proposed to act as a regulator of PDE delta-mediated transport of prenylated proteins.\",\n      \"method\": \"X-ray crystallography (two crystal forms, PDB: 1KSG, 1KSH, 1KSJ); co-expression and copurification; binding assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure solved at high resolution with multiple crystal forms, co-expression/copurification, and binding experiments in a single rigorous study\",\n      \"pmids\": [\"11980706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Arl2 in its GDP-bound form interacts with tubulin-specific chaperone cofactor D (TBCD) and downregulates the tubulin GAP activity of cofactors C, D, and E, inhibiting binding of D to native tubulin in vitro. GDP-Arl2 specifically prevents tubulin and microtubule destruction caused by cofactor D overexpression in cultured cells, but not by cofactor E. Established using Ras-family-based Arl2 point mutants in vitro and in vivo.\",\n      \"method\": \"In vitro tubulin GTPase assays; in vitro binding inhibition assays; overexpression in cultured cells; site-directed mutagenesis of Arl2\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (in vitro reconstitution, mutagenesis, cell-based assays) in a single rigorous study; independently supported by later work\",\n      \"pmids\": [\"10831612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"BART (Binder of Arl Two), a 19 kDa novel protein, was purified from bovine brain and identified as the first ARL2-specific effector. BART binds specifically to ARL2·GTP with high affinity but does not interact with ARL2·GDP, activated ARF, or RHO proteins. BART lacks GTPase-activating protein activity toward ARL2.\",\n      \"method\": \"Affinity purification from bovine brain; recombinant protein binding assays; GTPase activity assays; Northern and Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — purification of endogenous complex, recombinant protein validation, replicated in multiple subsequent studies\",\n      \"pmids\": [\"10488091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ARL2 and BART both localize to mitochondria in a protease-resistant form. ARL2 lacks N-myristoylation (unlike other ARF family members), preserving its N-terminal amphipathic helix as a potential mitochondrial import sequence. The BART·ARL2·GTP complex specifically binds the adenine nucleotide transporter ANT1 (but not the homologous ANT2) in mitochondria. Mitochondria from ant1−/− mice showed increased ARL2 levels, indicating that ARL2 in mitochondria is regulated via an ANT1-sensitive pathway.\",\n      \"method\": \"Subcellular fractionation; protease protection assay; overlay assay; protein purification and microsequencing; ant1−/− knockout mouse mitochondria analysis\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods including protease protection, overlay assay, purification, and genetic knockout validation\",\n      \"pmids\": [\"11809823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ELMOD2 was purified from bovine testis and identified as an ARL2 GTPase-activating protein (GAP). A second ELMO domain protein, ELMOD1, also has ARL2 GAP activity. Surprisingly, ELMOD2 also exhibits GAP activity against Arf proteins despite lacking the canonical Arf GAP sequence signature.\",\n      \"method\": \"Protein purification from bovine testis; in vitro GAP activity assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — biochemical purification of endogenous GAP activity and in vitro reconstitution; single lab but rigorous biochemical approach\",\n      \"pmids\": [\"17452337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Cytosolic Arl2 exists predominantly (~90%) as part of a ~300 kDa complex containing cofactor D (TBCD) and at least two distinct protein phosphatase 2A (PP2A) trimers (all three PP2A subunits identified by mass spectrometry). Arl2 in this complex cannot bind GTP, and complexed cofactor D does not efficiently participate in tubulin refolding reactions. This suggests the complex sequesters both Arl2 and TBCD in inactive states.\",\n      \"method\": \"Gel filtration; ~500-fold purification from bovine brain soluble fraction; mass spectrometry protein identification; GTP-binding assays; tubulin refolding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — biochemical purification, mass spectrometry identification, and functional activity assays in a single study\",\n      \"pmids\": [\"12912990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"C. elegans evl-20, a functional homolog of human ARL2, is required for cytoskeletal dynamics during cytokinesis and morphogenesis. Loss of evl-20 causes microtubule cytoskeleton defects and developmental abnormalities. EVL-20 localizes to the cell cortex and astral microtubules.\",\n      \"method\": \"Loss-of-function genetics (C. elegans); immunofluorescence localization; phenotypic analysis\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined cellular phenotype and localization; ortholog of ARL2 in C. elegans\",\n      \"pmids\": [\"12015966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Expression of constitutively active [Q70L]Arl2 in HeLa cells caused loss of microtubules and cell cycle arrest in M phase, attributed to a defect in tubulin polymerization. Arl2 was found to localize to centrosomes. Arl3 knockdown (not Arl2 knockdown) caused cytokinesis failure and binucleation, distinguishing the two paralogs' roles in microtubule-dependent processes.\",\n      \"method\": \"siRNA knockdown; dominant-active mutant expression; immunofluorescence; cell cycle analysis\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — multiple mutant/knockdown experiments with defined phenotypic readouts; single lab\",\n      \"pmids\": [\"16525022\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"miR-15b targets the 3'-UTR of Arl2 mRNA and suppresses Arl2 mRNA and protein expression. Knockdown of Arl2 by siRNA decreases cellular ATP levels and causes mitochondrial degeneration, phenocopying miR-15b overexpression. Restoration of Arl2 expression rescues the miR-15b-induced reduction in ATP levels.\",\n      \"method\": \"Luciferase reporter assay (3'-UTR); siRNA knockdown; miRNA overexpression; ATP assay; electron microscopy of mitochondria\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase reporter validation, rescue experiment, and EM phenotype; single lab\",\n      \"pmids\": [\"20007690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Crystal structure of the RPGR propeller domain in complex with PDEδ was solved, revealing that RPGR binds cargo-loaded PDEδ via a conserved surface patch while exposing the Arl2/Arl3-binding site on PDEδ. Biochemical experiments showed RPGR can bind with high affinity to cargo-loaded PDEδ, suggesting RPGR acts as a scaffold recruiting cargo-loaded PDEδ and Arl3 to release lipidated cargo into cilia.\",\n      \"method\": \"X-ray crystallography; biochemical binding assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure plus biochemical experiments; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"23559067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"HRG4 (UNC119) interacts with ARL2 as identified by yeast two-hybrid; confirmed by co-immunoprecipitation and direct binding assay. ARL2 co-localizes with HRG4 in the retina. Conserved amino acid residues in HRG4 homologous to those in PDEδ that mediate ARL2 binding and form the hydrophobic pocket suggest a similar binding mechanism.\",\n      \"method\": \"Yeast two-hybrid; co-immunoprecipitation; direct binding assay; Western blot; immunofluorescence\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — multiple complementary binding assays (Y2H, co-IP, direct binding) in a single study\",\n      \"pmids\": [\"12527357\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ARL2 depletion by siRNA impairs mitochondrial morphology (fragmentation), motility, and ATP levels in cultured cells. These mitochondrial roles are distinct from ARL2's roles in tubulin folding. Knockdown of the ARL2 GAP ELMOD2 phenocopies two of three mitochondrial phenotypes of ARL2 siRNA (morphology and motility but not ATP), placing ELMOD2 as a likely effector downstream of ARL2 for mitochondrial functions.\",\n      \"method\": \"siRNA knockdown; dominant-negative mutant expression; live-cell imaging of mitochondrial morphology and motility; ATP assays; genetic epistasis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple phenotypic readouts and epistasis with ELMOD2; single lab\",\n      \"pmids\": [\"24911211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ARL2 is present in and required for mitochondrial fusion from the intermembrane space (IMS). Increased ARL2 activity promotes mitochondrial elongation/fusion, while loss of ARL2 decreases fusion rate. Activated ARL2 can partially rescue loss of MFN1 or MFN2 individually but not both together, placing ARL2 upstream of/parallel to mitofusins. IMS-restricted ARL2 constructs were active, while matrix or excluded constructs were inactive. By SIM microscopy, ARL2 and mitofusin immunoreactivities co-localize as puncta along mitochondria.\",\n      \"method\": \"Dominant-active/dominant-negative mutant expression; mitochondrial fusion assay; targeted subcellular localization constructs; structured illumination microscopy (SIM); MFN1/MFN2 knockout cell epistasis\",\n      \"journal\": \"Cellular logistics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal approaches (functional assays, localization constructs, KO epistasis, SIM imaging); single lab\",\n      \"pmids\": [\"28944094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ELMOD2 is required for ARL2-dependent mitochondrial elongation and fusion. Loss of ELMOD2 causes mitochondrial fragmentation and decreased fusion rate; ELMOD2 overexpression promotes tubulation and fusion in a mitofusin-dependent manner. A GAP-dead ELMOD2 mutant retains the ability to promote fusion, indicating ELMOD2 acts as an effector (not purely via GAP activity) downstream of ARL2 and upstream of mitofusins. ELMOD2, ARL2, MFN1/2, Miro1/2, and mitoPLD co-localize at discrete puncta along mitochondria.\",\n      \"method\": \"siRNA knockdown; ELMOD2 overexpression; GAP-dead mutant expression; mitochondrial fusion assay; confocal microscopy co-localization\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional assays and mutant analysis; single lab, builds on prior ARL2 mitochondrial work\",\n      \"pmids\": [\"30865555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A trimeric complex of TBCD·ARL2·β-tubulin was purified from mammalian cells and tissues. ARL2 (not β-tubulin) is the GTP-exchanging subunit in the trimer. ARL2 binds GTP with higher affinity in the trimer than as a monomer. ARL2 point mutants that disrupt TBCD binding impair microtubule density in cells. The trimer represents a functional intermediate in the β-tubulin folding pathway regulated by ARL2 nucleotide cycling.\",\n      \"method\": \"Native PAGE and immunoblotting; purification of trimer from HEK293 cells; hydrogen/deuterium exchange-mass spectrometry; nucleotide-binding assays; ARL2 point mutants; cell-based microtubule density assay\",\n      \"journal\": \"The Journal of biological chemistry; Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical purification, HDX-MS structural dynamics, nucleotide binding assays, and mutagenesis across two complementary studies from the same lab\",\n      \"pmids\": [\"28126905\", \"28970104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"siRNA-mediated suppression of ARL2 in HeLa cells overcomes the inability of human TBCD (which normally does not disrupt microtubules upon overexpression) to destroy microtubule integrity in vivo, confirming that Arl2 negatively regulates TBCD's microtubule-destructive activity in cells.\",\n      \"method\": \"siRNA knockdown of Arl2; TBCD overexpression; immunofluorescence of microtubules\",\n      \"journal\": \"Cytoskeleton\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean siRNA rescue epistasis experiment; single lab, single method\",\n      \"pmids\": [\"20740604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Drosophila Arl2 controls microtubule growth and asymmetric division of neural stem cells (neuroblasts) by localizing Msps (XMAP215 ortholog) to centrosomes via regulation of dynein function and centrosomal D-TACC/Msps localization. Arl2 physically associates with tubulin cofactors C, D, and E, and functions together with cofactor D (TBCD) to control microtubule growth. Arl2 loss-of-function causes microtubule abnormalities and asymmetric division defects; Arl2 overactivation causes microtubule overgrowth and NB depletion.\",\n      \"method\": \"RNAi knockdown; dominant-negative and activated mutant expression; co-immunoprecipitation with TBCC/D/E; immunofluorescence; genetic epistasis in Drosophila NBs\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP with multiple cofactors, multiple loss/gain-of-function genetics, imaging in vivo, epistasis; multiple orthogonal methods in Drosophila ortholog\",\n      \"pmids\": [\"26953351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Arl2 and Arl3 both release prenylated and myristoylated cargo from carrier proteins (PDEδ for prenylated cargo; Unc119a/b for myristoylated cargo), but differ in selectivity: Arl3·GTP exclusively releases high-affinity ciliary cargo from Unc119, while both Arl2·GppNHp and Arl3·GppNHp can release low-affinity cargo. Crystal structure of myristoylated NPHP3 peptide in complex with Unc119a revealed molecular determinants of high-affinity binding; swapping residues at +2/+3 positions reversed cargo affinities and caused partial mislocalization.\",\n      \"method\": \"X-ray crystallography; fluorescence polarization binding assays; mutagenesis; cell localization studies\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure, quantitative binding assays, mutagenesis, and cell localization in a single study\",\n      \"pmids\": [\"27481943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"BART interacts with GTP-bound ARL2 at the leading edges of migrating pancreatic cancer cells. GTP-bound ARL2 inactivates RhoA, and BART prevents ARL2 from regulating RhoA activity by binding GTP-ARL2, thereby increasing active RhoA levels. BART functions as an inhibitor of ARL2 at leading edges, and BART knockdown reduces active RhoA, increases actin-cytoskeleton rearrangements, and promotes cell invasion.\",\n      \"method\": \"Co-immunoprecipitation; RhoA activation assay; siRNA knockdown of BART; Rho inhibitor (C3 exoenzyme) treatment; invasion assay; immunofluorescence\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — co-IP, activation assays, and functional knockdown with pharmacological validation; single lab\",\n      \"pmids\": [\"21833473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In polarized epithelial MDCK cells, ARL2 and TBCD (beta-tubulin cofactor D) participate in apical junctional complex (AJC) disassembly and cell dissociation from the epithelial monolayer independently of microtubule depolymerization. TBCD partially localizes to the lateral plasma membrane via its 15 C-terminal amino acids and requires intact microtubules for this. ARL2 inhibits TBCD-dependent cell dissociation and AJC disassembly.\",\n      \"method\": \"Overexpression in MDCK cells; immunofluorescence; dominant-active/inactive ARL2 constructs; microtubule depolymerization assays\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — functional overexpression assays with defined phenotypic readout and inhibition by ARL2; single lab\",\n      \"pmids\": [\"17704193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ELMOD3, a second ELMO domain-containing protein, exhibits GAP activity against Arl2 GTPase; this activity is completely abolished by the disease-causing p.Leu265Ser mutation in the ELMO domain. ELMOD3 co-localizes with the actin cytoskeleton in epithelial cells and is expressed in cochlear hair cell stereocilia.\",\n      \"method\": \"Recombinant GST-ELMOD3 in vitro GAP assay; site-directed mutagenesis; immunofluorescence; exome sequencing/co-segregation for human genetics\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro GAP assay with mutagenesis validation; single lab\",\n      \"pmids\": [\"24039609\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The solution structure of BART was solved by NMR, revealing a novel fold of six alpha-helices forming three interlocking 'L' shapes. Mapping of ARL2-binding regions onto the surface showed they localize to dynamic loop regions between central helices.\",\n      \"method\": \"NMR structure determination; backbone dynamics analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — NMR structure solved but functional validation is limited in this paper; single lab\",\n      \"pmids\": [\"18981177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In Trypanosoma brucei, TbARL2 RNAi causes inhibition of cleavage furrow formation, cytokinesis defects, multinucleation, and loss of acetylated alpha-tubulin (but not total tubulin) from microtubules. Overexpression of myc-tagged (but not untagged) TbARL2 also causes cytokinesis defects, demonstrating importance of the C-terminus for correct function.\",\n      \"method\": \"RNAi in bloodstream T. brucei; overexpression; immunofluorescence; Western blot\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi with defined cellular phenotypes and overexpression controls; ortholog of ARL2 in protozoan\",\n      \"pmids\": [\"20653091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Fission yeast cofactor C ortholog Tbc1 acts as a GAP for Alp41/Arl2 (S. pombe Arl2). Continuous cycling between GDP- and GTP-bound Alp41 is required for microtubule function (both constitutive GDP and GTP forms cause microtubule loss). GDP-bound Alp41 interacts with Alp1D (cofactor D ortholog), and Alp1D co-overproduction with GDP-Alp41 prevents Alp1D-induced microtubule depolymerization.\",\n      \"method\": \"In vitro GAP assay; genetic analysis of GDP/GTP mutants in S. pombe; co-immunoprecipitation; fluorescence microscopy\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro GAP assay, genetic epistasis, Co-IP in fission yeast ortholog; single lab\",\n      \"pmids\": [\"23576550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Novel PDE6δ inhibitors with picomolar affinity (up to 7 hydrogen bonds to PDE6δ) are poorly released from PDE6δ by Arl2, unlike earlier lower-affinity inhibitors that are rapidly displaced. This demonstrates that Arl2 functions as a release factor for PDE6δ-bound cargo/inhibitors and that inhibitor affinity determines the efficiency of Arl2-mediated displacement.\",\n      \"method\": \"Biophysical binding assays (SPR/ITC); cellular KRas signaling assays; cell viability assays; structure-activity relationship chemistry\",\n      \"journal\": \"Angewandte Chemie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — binding assays plus cellular functional assays; mechanistic point about Arl2 release activity validated with chemical probes\",\n      \"pmids\": [\"28106325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Arl2 binds to membranes in a nucleotide-independent manner (unlike Arl3 and other Arfs that require GTP for membrane interaction). Arl2 and Arl3 both preferentially localize to liquid-disordered membrane domains. In contrast to Arl3, the N-terminal helix of Arl2 does not increase binding affinity to UNC119a, and UNC119a does not impede Arl2 membrane binding.\",\n      \"method\": \"Biophysical membrane-binding assays (fluorescence spectroscopy with phase-separated vesicles); nucleotide loading comparisons\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — rigorous biophysical assays but single lab, distinguishing Arl2 from Arl3 membrane behavior\",\n      \"pmids\": [\"26488653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Molecular dynamics simulations revealed that Arl2·GTP binding to PDE6δ allosterically compresses the hydrophobic pocket via changes in β6 of PDEδ and additional residues, pushing the KRas4B farnesylated HVR out. Mutating PDEδ residues mediating these allosteric changes abolishes the release process.\",\n      \"method\": \"All-atom molecular dynamics simulation; mutational analysis of PDEδ allosteric residues\",\n      \"journal\": \"The journal of physical chemistry B\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational study only; mutagenesis is in silico; no experimental validation in this paper\",\n      \"pmids\": [\"29961325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Mouse Arl2 physically associates with the centrosomal protein Cdk5rap2, validated by co-immunoprecipitation and proximity ligation assay (PLA). Arl2 knockdown in mouse neural progenitor cells reduces centrosomal microtubule growth and delocalizes centrosomal proteins Cdk5rap2 and γ-tubulin. Overexpression of Cdk5rap2 rescues the neurogenesis defects caused by Arl2 knockdown, placing Cdk5rap2 downstream of Arl2 in cortical development.\",\n      \"method\": \"Co-immunoprecipitation; proximity ligation assay; in utero electroporation knockdown; rescue by Cdk5rap2 overexpression; live imaging of centrosomal microtubule growth\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus PLA for interaction, genetic rescue epistasis, live imaging; single lab\",\n      \"pmids\": [\"39137170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Conditional deletion of ARL2 in the mouse retina early in development (retArl2−/−) disrupts the microtubule cytoskeleton as early as postnatal day 6, prevents rod and cone outer segment formation, and reduces cytoplasmic dynein levels in inner segments, suggesting dynein stability depends on a functional microtubule cytoskeleton organized by ARL2. Rod-specific late deletion was stable, indicating ARL2 is specifically required during early photoreceptor development for microtubule neogenesis.\",\n      \"method\": \"Conditional knockout mouse; immunofluorescence; Western blot; ERG functional assay\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with multiple cellular phenotype readouts; single lab\",\n      \"pmids\": [\"36611941\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A de novo variant in ARL2 (p.R15L) causes MRCS syndrome. Co-immunoprecipitation showed the mutant ARL2 protein has 62% lower binding affinity for HRG4 but only 18% lower binding affinity for ARL2BP. ARL2 and HRG4 co-localize with cytochrome c in HeLa cells, indicating mitochondrial co-localization. Mutant ARL2 causes abnormalities in mitochondrial respiratory chain function and ATP production. Transgenic mice expressing the mutant develop retinal degeneration, microcornea, and cataract.\",\n      \"method\": \"Co-immunoprecipitation; immunofluorescence; mitochondrial function assays; ATP production assay; site-directed mutagenesis; transgenic mouse model\",\n      \"journal\": \"Clinical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (Co-IP, functional assays, transgenic model); single lab\",\n      \"pmids\": [\"30945270\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ARL2 is required for homologous recombination repair (HRR) in colon cancer stem cells (CSCs). ARL2 depletion leads to DNA double-strand break accumulation and apoptosis specifically in CSCs. ARL2 is detected within chromatin compartments and its expression correlates with RAD51 family gene expression.\",\n      \"method\": \"siRNA depletion; DNA damage assays; subcellular fractionation (chromatin compartment); flow cytometry (apoptosis, cell cycle)\",\n      \"journal\": \"FEBS open bio\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — functional knockdown with chromatin fractionation; single lab, limited mechanistic detail on how ARL2 mediates HRR\",\n      \"pmids\": [\"35567502\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ARL2 is a small regulatory GTPase that cycles between GDP- and GTP-bound states (regulated by GAPs including ELMOD1/2/3 and TBCC/Tbc1) and functions in at least three distinct cellular contexts: (1) in the cytosol, GDP-ARL2 binds tubulin chaperone TBCD within a TBCD·ARL2·β-tubulin trimer to regulate β-tubulin folding and microtubule dynamics, inhibiting TBCD's destructive activity while ARL2 nucleotide exchange drives conformational changes in β-tubulin; (2) inside mitochondria (in the intermembrane space, lacking N-myristoylation), ARL2·GTP promotes mitochondrial fusion via the ELMOD2 effector acting upstream of mitofusins, and interacts with ANT1 to regulate adenine nucleotide transport and ATP levels; and (3) in the context of lipidated cargo trafficking, ARL2·GTP and Arl3·GTP act as release factors from carrier proteins PDE6δ (for farnesylated cargo such as KRas) and UNC119 (for myristoylated cargo), with Arl3 exclusively releasing high-affinity ciliary cargo while Arl2 releases low-affinity cargo, supporting a spatial sorting mechanism for protein delivery to cilia and the plasma membrane.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ARL2 is a small ADP-ribosylation factor-like GTPase that cycles between GDP- and GTP-bound states and coordinates microtubule biogenesis, mitochondrial function, and the trafficking of lipidated proteins across spatially distinct cellular pools [#0, #1, #11]. Its nucleotide cycle is governed by GAPs of the ELMO-domain family (ELMOD1, ELMOD2, ELMOD3) and by tubulin cofactor C orthologs, with continuous GDP/GTP cycling required for activity [#4, #20, #23]. In the cytosol, GDP-bound ARL2 binds tubulin-specific chaperone cofactor D (TBCD) and assembles into a TBCD·ARL2·\\u03b2-tubulin trimer in which ARL2 is the GTP-exchanging subunit; through this complex ARL2 restrains TBCD's tubulin- and microtubule-destructive activity and drives the \\u03b2-tubulin folding pathway, controlling microtubule density, centrosomal microtubule growth, and cell-cycle progression [#1, #5, #14, #15, #27]. Inside mitochondria, where ARL2 escapes N-myristoylation and is imported to the intermembrane space, ARL2·GTP promotes mitochondrial fusion through the ELMOD2 effector acting with the mitofusins and regulates ATP levels and mitochondrial morphology, in part via interaction with the adenine nucleotide transporter ANT1 [#3, #11, #12, #13]. In lipidated-cargo trafficking, ARL2·GTP acts as a release factor that allosterically expels prenylated cargo from the carrier PDE\\u03b4 and myristoylated cargo from UNC119, with ARL2 releasing low-affinity cargo while the paralog Arl3 handles high-affinity ciliary cargo, establishing a spatial sorting mechanism [#0, #17, #24]. The dedicated effector BART (BinderofArlTwo) binds ARL2·GTP specifically and modulates its activity, including at the leading edge of migrating cells where it antagonizes ARL2-dependent suppression of RhoA [#2, #18]. A de novo ARL2 variant (p.R15L) that weakens binding to HRG4/UNC119 causes MRCS syndrome with retinal degeneration, microcornea, and cataract [#29].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing that ARL2 has dedicated GTP-state-specific effectors answered whether it functions as a genuine signaling GTPase rather than a structural ARF; BART was the first such effector identified.\",\n      \"evidence\": \"Affinity purification of BART from bovine brain with recombinant binding and GTPase assays\",\n      \"pmids\": [\"10488091\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular consequence of BART binding undefined at discovery\", \"No structure of the ARL2-BART complex\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Linking GDP-ARL2 to the tubulin chaperone cofactor D established its first concrete role: a negative regulator of cofactor-driven tubulin destruction and microtubule integrity.\",\n      \"evidence\": \"In vitro tubulin GTPase and binding-inhibition assays plus cofactor overexpression in cultured cells with ARL2 point mutants\",\n      \"pmids\": [\"10831612\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve whether ARL2 is part of a stable trimer with tubulin\", \"Nucleotide-cycle requirement not directly tested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Solving the Arl2-GTP·PDE\\u03b4 structure showed how ARL2 nucleotide state controls a prenyl-binding carrier, framing ARL2 as a regulator of prenylated-protein transport.\",\n      \"evidence\": \"X-ray crystallography of full-length Arl2-GTP·PDE\\u03b4 in two crystal forms with binding assays\",\n      \"pmids\": [\"11980706\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Release mechanism for cargo not directly demonstrated\", \"In vivo trafficking consequences not tested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrating mitochondrial localization and ANT1 binding of the BART·ARL2·GTP complex revealed an unexpected second compartment for ARL2 beyond tubulin folding.\",\n      \"evidence\": \"Subcellular fractionation, protease protection, overlay assay, and ant1-/- mouse mitochondria analysis\",\n      \"pmids\": [\"11809823\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of ANT1 interaction not established\", \"Mechanism of mitochondrial import not defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defining the ~300 kDa cytosolic ARL2-TBCD-PP2A complex clarified that most cellular ARL2 is held in a GTP-incompetent, sequestered state, implying regulated release governs activity.\",\n      \"evidence\": \"Gel filtration, purification from bovine brain, mass spectrometry, GTP-binding and tubulin refolding assays\",\n      \"pmids\": [\"12912990\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal that releases ARL2/TBCD from the complex unknown\", \"Role of PP2A in the complex not mechanistically resolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identifying UNC119/HRG4 as an ARL2 partner extended the carrier-protein paradigm from prenylated to myristoylated cargo and connected ARL2 to retinal biology.\",\n      \"evidence\": \"Yeast two-hybrid, co-IP, direct binding, and retinal co-localization\",\n      \"pmids\": [\"12527357\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cargo release from UNC119 not yet shown\", \"Functional retinal consequence not tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showing that constitutively active ARL2 destroys microtubules and arrests cells in M phase while distinguishing ARL2 from Arl3 separated the paralogs' roles in microtubule-dependent processes.\",\n      \"evidence\": \"siRNA knockdown, dominant-active mutant expression, immunofluorescence, and cell-cycle analysis in HeLa cells\",\n      \"pmids\": [\"16525022\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Centrosomal function of ARL2 not mechanistically defined\", \"Single-lab phenotype\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identifying ELMOD2 (and ELMOD1) as ARL2 GAPs provided the missing regulators that terminate ARL2 signaling, defining the off-switch of its cycle.\",\n      \"evidence\": \"Purification of GAP activity from bovine testis and in vitro GAP assays\",\n      \"pmids\": [\"17452337\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which ARL2 functions each GAP regulates not yet assigned\", \"Cross-activity toward Arf raised specificity questions\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identifying ELMOD3 as a third ARL2 GAP whose activity is abolished by a disease mutation, and resolving RPGR scaffolding of cargo-loaded PDE\\u03b4, sharpened both the regulatory network and the ciliary-delivery model.\",\n      \"evidence\": \"In vitro GAP assays with mutagenesis (ELMOD3) and crystallography with binding assays (RPGR-PDE\\u03b4)\",\n      \"pmids\": [\"24039609\", \"23559067\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct role of ARL2 (vs Arl3) in RPGR-mediated release not pinned down\", \"Tissue specificity of GAP usage unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Separating ARL2's mitochondrial phenotypes (morphology, motility, ATP) from its tubulin role, and placing ELMOD2 downstream, established a distinct mitochondrial pathway.\",\n      \"evidence\": \"siRNA knockdown, dominant-negative expression, live imaging, ATP assays, and ELMOD2 epistasis\",\n      \"pmids\": [\"24911211\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular target of ARL2 in mitochondria not identified\", \"ATP defect not phenocopied by ELMOD2 loss\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrating ARL2/Arl3 cargo release and its affinity-based selectivity, and dissecting ARL2's centrosomal microtubule control in Drosophila neuroblasts, unified the trafficking and microtubule arms mechanistically.\",\n      \"evidence\": \"Crystallography and fluorescence polarization (cargo release); RNAi, Co-IP with cofactors C/D/E, and imaging in Drosophila neuroblasts\",\n      \"pmids\": [\"27481943\", \"26953351\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a single GTPase is partitioned among compartments unresolved\", \"Quantitative cargo handoff to membranes in cells incomplete\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Reconstituting the TBCD·ARL2·\\u03b2-tubulin trimer with ARL2 as the GTP-exchanging subunit, and showing IMS-restricted ARL2 drives mitofusin-dependent fusion, gave direct biochemical mechanism for both the tubulin-folding and mitochondrial-fusion roles.\",\n      \"evidence\": \"Trimer purification with HDX-MS and nucleotide assays; targeted localization constructs, fusion assays, SIM, and MFN1/2 KO epistasis\",\n      \"pmids\": [\"28126905\", \"28970104\", \"28944094\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of ARL2-induced \\u03b2-tubulin conformational change not at atomic resolution\", \"Effector linking ARL2 to mitofusins not yet identified in this study\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showing ELMOD2 acts as a GAP-independent effector for ARL2-driven mitochondrial fusion, alongside identifying an ARL2 disease variant, connected mechanism to human pathology.\",\n      \"evidence\": \"GAP-dead ELMOD2 mutant fusion assays and co-localization; Co-IP, mitochondrial function assays, and transgenic mouse for the p.R15L MRCS variant\",\n      \"pmids\": [\"30865555\", \"30945270\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How the same ELMOD2 serves both GAP and effector roles unclear\", \"Whether MRCS pathology is primarily trafficking- or mitochondria-driven not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identifying Cdk5rap2 as an ARL2-associated centrosomal target whose overexpression rescues ARL2-loss neurogenesis defects extended ARL2's microtubule role into cortical development.\",\n      \"evidence\": \"Co-IP, proximity ligation, in utero electroporation knockdown, rescue, and live imaging in mouse neural progenitors\",\n      \"pmids\": [\"39137170\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether ARL2 nucleotide state controls Cdk5rap2 localization unknown\", \"Direct vs indirect interaction not fully resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a single GTPase is partitioned and selectively activated across its cytosolic tubulin-folding, mitochondrial, and membrane-trafficking pools, and how its sequestered cytosolic complex is mobilized, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No mechanism for compartment-specific GEF/GAP targeting\", \"Release mechanism from the inhibitory TBCD-PP2A complex unknown\", \"ARL2 chromatin/HRR role (Low confidence) lacks direct mechanism\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [4, 14, 20, 23]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 15, 17, 24]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [1, 14, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5, 14]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [3, 11, 12, 13]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [7, 27]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [25, 18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [1, 14, 12]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [0, 17]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"complexes\": [\n      \"TBCD\\u00b7ARL2\\u00b7\\u03b2-tubulin trimer\",\n      \"ARL2-TBCD-PP2A ~300 kDa complex\",\n      \"BART\\u00b7ARL2\\u00b7GTP complex\"\n    ],\n    \"partners\": [\n      \"TBCD\",\n      \"BART\",\n      \"PDE6D\",\n      \"UNC119\",\n      \"ELMOD2\",\n      \"ANT1\",\n      \"CDK5RAP2\",\n      \"ELMOD3\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":7,"faith_pct":85.71428571428571}}